Home/Pipeline/Thrombocid

Thrombocid

Arteriovenous Diseases

ApprovedActive

Key Facts

Indication
Arteriovenous Diseases
Phase
Approved
Status
Active
Companies

About bene-Arzneimittel

bene-Arzneimittel is a well-established, private German pharmaceutical company with a 70+ year legacy originating from its founder's synthesis of sodium pentosan polysulfate (NaPPS). Its business is built on a dual foundation: a portfolio of trusted, classic OTC products like ben-u-ron® for pain and fever, and a proprietary platform around the unique active substance NaPPS, which has led to approved prescription drugs. With approximately 120 employees, the company maintains full control over its supply chain through a subsidiary for API manufacturing and emphasizes quality production in Germany, while pursuing international expansion and new product development.

View full company profile

About Lacer

Lacer is a well-established, privately-held Spanish pharmaceutical company with a 75-year history. It operates as a commercial-stage entity with a diversified portfolio centered on OTC consumer healthcare brands in oral health, dermatology, and vascular care, alongside prescription medicines. The company leverages a global network of distribution partners to sell its products across Europe, Latin America, the Middle East, and Asia, indicating a stable, revenue-generating business model focused on mature markets and brand extensions.

View full company profile